Micro-X Ltd

AU:MX1 Australia Medical Devices
Market Cap
$30.12 Million
AU$48.65 Million AUD
Market Cap Rank
#24663 Global
#512 in Australia
Share Price
AU$0.07
Change (1 day)
+3.08%
52-Week Range
AU$0.04 - AU$0.12
All Time High
AU$0.60
About

Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or … Read more

Micro-X Ltd (MX1) - Net Assets

Latest net assets as of December 2025: AU$5.59 Million AUD

Based on the latest financial reports, Micro-X Ltd (MX1) has net assets worth AU$5.59 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$17.41 Million) and total liabilities (AU$11.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$5.59 Million
% of Total Assets 32.12%
Annual Growth Rate N/A
5-Year Change -77.9%
10-Year Change -58.59%
Growth Volatility 63.07

Micro-X Ltd - Net Assets Trend (2014–2025)

This chart illustrates how Micro-X Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Micro-X Ltd (2014–2025)

The table below shows the annual net assets of Micro-X Ltd from 2014 to 2025.

Year Net Assets Change
2025-06-30 AU$7.55 Million -47.07%
2024-06-30 AU$14.26 Million -16.74%
2023-06-30 AU$17.13 Million -10.90%
2022-06-30 AU$19.22 Million -43.70%
2021-06-30 AU$34.15 Million +131.72%
2020-06-30 AU$14.74 Million +594.86%
2019-06-30 AU$-2.98 Million -309.63%
2018-06-30 AU$-727.00K -104.74%
2017-06-30 AU$15.32 Million -15.93%
2016-06-30 AU$18.23 Million -35.87%
2015-06-30 AU$28.43 Million +7630.50%
2014-06-30 AU$-377.47K --

Equity Component Analysis

This analysis shows how different components contribute to Micro-X Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 13509123200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$138.35 Million 1832.94%
Other Comprehensive Income AU$4.60 Million 60.98%
Other Components AU$65.00K 0.86%
Total Equity AU$7.55 Million 100.00%

Micro-X Ltd Competitors by Market Cap

The table below lists competitors of Micro-X Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Micro-X Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 14,261,000 to 7,548,000, a change of -6,713,000 (-47.1%).
  • Net loss of 13,895,000 reduced equity.
  • Share repurchases of 355,000 reduced equity.
  • New share issuances of 6,365,000 increased equity.
  • Other comprehensive income increased equity by 502,000.
  • Other factors increased equity by 670,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-13.89 Million -184.09%
Share Repurchases AU$355.00K -4.7%
Share Issuances AU$6.37 Million +84.33%
Other Comprehensive Income AU$502.00K +6.65%
Other Changes AU$670.00K +8.88%
Total Change AU$- -47.07%

Book Value vs Market Value Analysis

This analysis compares Micro-X Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.42x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-06-30 AU$-0.02 AU$0.07 x
2015-06-30 AU$0.33 AU$0.07 x
2016-06-30 AU$0.28 AU$0.07 x
2017-06-30 AU$0.12 AU$0.07 x
2018-06-30 AU$-0.01 AU$0.07 x
2019-06-30 AU$-0.02 AU$0.07 x
2020-06-30 AU$0.06 AU$0.07 x
2021-06-30 AU$0.09 AU$0.07 x
2022-06-30 AU$0.04 AU$0.07 x
2023-06-30 AU$0.03 AU$0.07 x
2024-06-30 AU$0.03 AU$0.07 x
2025-06-30 AU$0.01 AU$0.07 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Micro-X Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -184.09%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -106.45%
  • • Asset Turnover: 0.59x
  • • Equity Multiplier: 2.93x
  • Recent ROE (-184.09%) is below the historical average (-57.89%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 0.00% 0.00% 0.00x 0.00x AU$-347.79K
2015 -35.75% -14115.28% 0.00x 1.09x AU$-13.01 Million
2016 -58.93% -1204.15% 0.04x 1.33x AU$-12.56 Million
2017 -84.31% -1960.55% 0.03x 1.68x AU$-14.45 Million
2018 0.00% -1032.67% 0.11x 0.00x AU$-16.52 Million
2019 0.00% -509.27% 0.20x 0.00x AU$-9.54 Million
2020 -68.31% -236.81% 0.13x 2.29x AU$-11.54 Million
2021 -43.14% -390.64% 0.08x 1.31x AU$-18.15 Million
2022 -88.89% -190.51% 0.29x 1.63x AU$-19.01 Million
2023 -62.79% -71.67% 0.50x 1.77x AU$-12.47 Million
2024 -68.47% -64.15% 0.57x 1.89x AU$-11.19 Million
2025 -184.09% -106.45% 0.59x 2.93x AU$-14.65 Million

Industry Comparison

This section compares Micro-X Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $14,750,885
  • Average return on equity (ROE) among peers: -315.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Micro-X Ltd (MX1) AU$5.59 Million 0.00% 2.11x $23.94 Million
4DMEDICAL Ltd (4DX) $926.64K -85.93% 0.18x $1.03 Billion
Adherium Ltd (ADR) $34.53 Million -3.63% 0.08x $2.37 Million
Aroa Biosurgery Ltd (ARX) $-22.65 Million 0.00% 0.00x $92.74 Million
Atomo Diagnostics Ltd (AT1) $34.48 Million -26.73% 0.05x $8.96 Million
Control Bionics Ltd (CBL) $6.09 Million -15.97% 0.04x $4.98 Million
Cardiex Ltd (CDX) $3.03 Million -101.61% 0.73x $4.25 Million
Compumedics Ltd (CMP) $9.21 Million -30.70% 1.16x $13.08 Million
Cochlear Ltd (COH) $75.42 Million 53.19% 1.13x $7.01 Billion
Cleo Diagnostics Ltd (COV) $5.83 Million -68.54% 0.19x $23.47 Million
Conneqt Health Limited (CQT) $633.50K -2871.98% 13.72x $4.66 Million